Detalhe da pesquisa
1.
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Prostate
; 79(4): 414-424, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560549
2.
Genetic factors influencing prostate cancer risk in Norwegian men.
Prostate
; 78(3): 186-192, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29181843
3.
Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
Prostate
; 78(16): 1222-1228, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043417
4.
Germline mutations in HOXB13 and prostate-cancer risk.
N Engl J Med
; 366(2): 141-9, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22236224
5.
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Nat Genet
; 32(2): 321-5, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12244320
6.
Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts.
J Cell Mol Med
; 16(1): 193-201, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21352472
7.
Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.
Int J Cancer
; 129(2): 424-32, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20878981
8.
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia.
Prostate
; 70(5): 473-81, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19902472
9.
Endoglin (CD105) as a urinary and serum marker of prostate cancer.
Int J Cancer
; 124(3): 664-9, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19004009
10.
alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.
Mol Cancer Ther
; 7(6): 1386-97, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18566211
11.
Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Oncotarget
; 8(14): 22772-22782, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186998
12.
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Eur Urol
; 71(5): 740-747, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27989354
13.
Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.
Cancer Res
; 64(7): 2523-33, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15059908
14.
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
Cancer Res
; 63(21): 7365-76, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14612535
15.
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Cancer Res
; 62(8): 2220-6, 2002 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11956072
16.
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
Oncotarget
; 7(45): 72593-72607, 2016 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683042
17.
In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Oncogene
; 21(17): 2679-94, 2002 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-11965541
18.
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
Cancer Epidemiol Biomarkers Prev
; 24(9): 1366-72, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26108461
19.
Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
Cancer Genet Cytogenet
; 137(1): 1-7, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12377406
20.
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Nat Med
; 15(5): 559-65, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19363497